Hironori Ninomiya

RET, ROS1 and ALK fusions in lung cancer

Kengo Takeuchi, Manabu Soda, Yuki Togashi et al. · Nature Medicine · 2012 · 1.3K citations

Oncology, Medicine, Cancer Genetics +4

EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

Kentaro Inamura, Kengo Takeuchi, Yuki Togashi et al. · Journal of Thoracic Oncology · 2008 · 464 citations · Full text

Lung Cancers, Tumor Biology, Oncology +12

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset

Kentaro Inamura, Kengo Takeuchi, Yuki Togashi et al. · Modern Pathology · 2009 · 443 citations

Tumor Biology, Young Onset, Medicine +9

P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

Ryohei Katayama, Takuya Sakashita, Noriko Yanagitani et al. · EBioMedicine · 2015 · 139 citations · Full text

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer

Rie Sakakibara, Kentaro Inamura, Yuichi Tambo et al. · Clinical Lung Cancer · 2016 · 127 citations

Medicine, Promising Method, Tumor Pd-l1 Expression +9